about
Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma.Small regulatory RNAs in Archaea.MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value.Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarkerNFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response.Diverse functions of miR-373 in cancer.Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsmiR-30e* is an independent subtype-specific prognostic marker in breast cancerAberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.miR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells.Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model.Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells.miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT.Influence of sex differences on microRNA gene regulation in disease.Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer.MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.Differential microRNA expression is associated with androgen receptor expression in breast cancerMicroRNAs in cancer therapeutic response: Friend and foeThe fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review).Roles of microRNA-140 in stem cell-associated early stage breast cancer.The "busy life" of unliganded estrogen receptors.Entrainment of Breast Cell Lines Results in Rhythmic Fluctuations of MicroRNAs.Breast cancer stem cells programs: enter the (non)-code.Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectives.DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers.
P2860
Q33599465-DBFC1CCD-1054-4969-A5EC-A77529CD5BA8Q34092121-1E64CA2B-CF86-4771-BA55-0379B76B7120Q34122750-56900612-29B7-41A4-9F60-F28AD17E6600Q34334484-29314D34-B06A-4C51-A79F-965260CD5392Q34583795-ED162C7A-B831-478D-821C-4ED7E179075DQ34979662-A0821823-B481-4F9F-A8D8-2537F1957F93Q35247522-2712BCD3-3E3B-48C4-9D51-9DB1E16228A7Q35469769-817D129F-3CEF-4B8F-9D1F-26FA50773CF1Q35599434-9C8DC554-7F32-4FF4-AB68-CB9267D48395Q35739548-C0E21D2A-C165-4622-8D68-E895A6F83BBFQ35814536-8FB800CF-3CF3-4685-8AA4-8303E59507DFQ35835164-E840020D-8FE7-470C-8DFE-504147ACB368Q35863168-436C3412-9BB4-4D16-957D-CD7B4AFE617EQ35936553-7F0CEAA6-ED8E-409B-9B62-FDEB8DCA99F0Q36157026-B2AB68E9-B959-4EDA-A653-27049304791CQ36299580-77412864-72EE-4F7E-9609-BE9D988CDB51Q36520345-618B5743-48E1-4827-B483-C13E83828C1AQ36647044-89CC36C3-5E23-45BF-8062-2171AD0431CAQ36797287-ED4CF5A5-7351-482A-8312-632B3A9D0FFBQ36898429-19AF3AA7-DC14-439A-AB58-13365DA6A4EFQ37034861-87341E0C-4458-453D-B83A-4408B854CA36Q37392880-E638BF99-FD91-4740-8E69-3EB6BD82862AQ37400824-EEF9984D-17A7-4128-8079-23424F2709ABQ37514118-EFEAD09E-342D-4EEA-9767-E61473DB951BQ37548074-3CF571EC-03AD-42AB-B523-B7A04822F5F9Q37549953-FD5421DE-F1AC-486F-8A2C-767619AC1BF4Q37564492-9B7AA403-F75D-441A-B4DD-3FA6CF2DC529Q37625750-2576F085-29BC-4CE4-B240-30CED9F4290EQ37626754-FEED2CCF-3278-429F-B3F6-9C2D3624E337Q37645010-4013726D-1B4C-4F0F-9AEB-B192AFFF6D5EQ37697914-ADB8737D-BD60-469C-B4DC-3541756F0B76Q37707636-005AD56E-6704-4748-B620-B9ED05AD32C1Q38258754-CDBA4F09-C752-4002-BC4D-4B81642DBC1FQ38262017-32D31AC3-3E32-4FEB-B9FC-4B3B9AE180C3Q38271600-ED41C461-91C0-4BA1-A84D-49026CF72D08Q38618003-A0641EC0-F2A6-41CA-8169-C7EFFCD6EF60Q38697420-2D86EFC9-F67D-4B2C-8581-5CD0B93D4DB9Q38765793-7285EF80-A174-42BB-A2CE-3820CF8A10B7Q38779433-72CA0797-0394-4C47-A05E-BB2C5770F6F2Q38864434-CBEA7558-2E7F-4D94-93A2-96F66640CC3E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
miRNA dysregulation in breast cancer.
@en
type
label
miRNA dysregulation in breast cancer.
@en
prefLabel
miRNA dysregulation in breast cancer.
@en
P1433
P1476
miRNA dysregulation in breast cancer
@en
P2093
Laoighse Mulrane
Sharon F McGee
P304
P356
10.1158/0008-5472.CAN-13-1841
P407
P577
2013-11-07T00:00:00Z